TELA Bio
TELA
30 hedge funds and large institutions have $130M invested in TELA Bio in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 8 closing their positions.
22% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 9
4.08% more ownership
Funds ownership: 72.63% → 76.71% (+4.1%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4% less capital invested
Capital invested by funds: $135M → $130M (-$5.01M)
17% less funds holding
Funds holding: 36 → 30 (-6)
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EWM
Essex Woodlands Management
The Woodlands,
Texas
|
+$17.1M |
| 2 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
+$1.83M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$528K |
| 4 |
WP
WMS Partners
Towson,
Maryland
|
+$341K |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$328K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
-$5.55M |
| 2 |
RI
RTW Investments
New York
|
-$4.63M |
| 3 |
AC
Armistice Capital
New York
|
-$1.89M |
| 4 |
Goldman Sachs
New York
|
-$252K |
| 5 |
Two Sigma Advisers
New York
|
-$152K |
TELA Hedge Fund Activity: Q1 2022 in Review
30 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in TELA Bio (TELA) for Q1 2022, worth a combined $130M — down 3.7% from $135M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of TELA and 2 opened new positions — a net loss of 6 holders — while 9 trimmed existing stakes and 11 added.
The largest buyer was Essex Woodlands Management, adding an estimated $17.1M. The largest seller was Cowen and Company, exiting entirely with an estimated $5.55M sold.
- 30 institutional investors held TELA Bio (TELA) as of Q1 2022, down from 36 in Q4 2021.
- Funds reported $130M of TELA Bio stock for Q1 2022, down 3.7% quarter-over-quarter.
- 2 funds opened new TELA Bio positions in Q1 2022 and 8 closed out, a net change of -6 holders.
- The largest TELA Bio buyer in Q1 2022 was Essex Woodlands Management, an estimated $17.1M added.
- The largest TELA Bio seller in Q1 2022 was Cowen and Company, an estimated $5.55M sold.
Based on aggregated 13F filings for Q1 2022.